• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonselective Beta-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation?

作者信息

Garcia-Tsao Guadalupe, Abraldes Juan G

机构信息

Digestive Diseases Section, VA-CT Healthcare System, West Haven, Connecticut, USA; Digestive Diseases Section, Yale School of Medicine, New Haven, Connecticut, USA.

Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Canada.

出版信息

Gastroenterology. 2021 Sep;161(3):770-773. doi: 10.1053/j.gastro.2021.04.077. Epub 2021 May 11.

DOI:10.1053/j.gastro.2021.04.077
PMID:33989660
Abstract
摘要

相似文献

1
Nonselective Beta-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation?非选择性β受体阻滞剂用于代偿期肝硬化：预防静脉曲张出血还是预防失代偿？
Gastroenterology. 2021 Sep;161(3):770-773. doi: 10.1053/j.gastro.2021.04.077. Epub 2021 May 11.
2
Preventing the development of varices in cirrhosis.预防肝硬化患者静脉曲张的发生。
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S300-4. doi: 10.1097/MCG.0b013e318157c63d.
3
Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.肝体积指数可预测普萘洛尔预防肝硬化患者食管静脉曲张出血的风险。
Korean J Intern Med. 2019 Nov;34(6):1233-1243. doi: 10.3904/kjim.2018.120. Epub 2019 Feb 18.
4
NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW".肝硬化患者使用非选择性β受体阻滞剂：“治疗窗”
Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):23-8.
5
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.β受体阻滞剂或安慰剂用于食管静脉曲张一级预防（BOPPP）：一项随机对照试验的研究方案。
Trials. 2024 Apr 16;25(1):265. doi: 10.1186/s13063-024-08063-3.
6
Prevention of the development of varices and first portal hypertensive bleeding episode.预防静脉曲张的发生及首次门静脉高压出血事件。
Best Pract Res Clin Gastroenterol. 2007;21(1):31-42. doi: 10.1016/j.bpg.2006.06.001.
7
Beta-blockers to prevent gastroesophageal varices in cirrhosis.β受体阻滞剂预防肝硬化患者食管胃静脉曲张
N Engl J Med. 2006 Mar 23;354(12):1318-20; author reply 1318-20. doi: 10.1056/NEJMc053519.
8
Primary prophylaxis of variceal bleeding.静脉曲张出血的一级预防
Gastroenterol Clin North Am. 2014 Dec;43(4):783-94. doi: 10.1016/j.gtc.2014.08.008. Epub 2014 Sep 22.
9
Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding.肝硬化患者的食管静脉曲张：从静脉曲张筛查到首次食管静脉曲张出血的一级预防。
Liver Int. 2011 Jan;31(1):108-19. doi: 10.1111/j.1478-3231.2010.02351.x. Epub 2010 Oct 14.
10
[Therapeutic and prevention strategies of gastroesophageal varices and variceal hemorrhage in cirrhosis].[肝硬化食管胃静脉曲张及曲张静脉出血的治疗与预防策略]
Zhonghua Gan Zang Bing Za Zhi. 2009 Apr;17(4):252-3.

引用本文的文献

1
Understanding clinically significant portal hypertension: an in-depth look at pathogenesis, diagnosis and treatment.了解具有临床意义的门静脉高压症：深入探讨发病机制、诊断与治疗
Ann Gastroenterol. 2025 Jul-Aug;38(4):380-391. doi: 10.20524/aog.2025.0980. Epub 2025 Jun 25.
2
Role of Spleen Stiffness Measurements with 2D Shear-Wave Elastography for Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.二维剪切波弹性成像测量脾脏硬度在代偿期晚期慢性肝病患者食管静脉曲张中的作用
Diagnostics (Basel). 2025 Mar 10;15(6):674. doi: 10.3390/diagnostics15060674.
3
Optimizing muscle preservation during weight loss in patients with cirrhosis: A pilot study comparing continuous energy restriction to alternate-day modified fasting for weight loss in patients with obesity and non-alcoholic cirrhosis of the liver.
肝硬化患者减肥期间肌肉保护的优化：一项比较持续能量限制与隔日改良禁食对肥胖和非酒精性肝硬化患者减肥效果的初步研究。
Obes Sci Pract. 2024 Oct 24;10(5):e70016. doi: 10.1002/osp4.70016. eCollection 2024 Oct.
4
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.阿替利珠单抗联合贝伐单抗治疗肝细胞癌患者的真实世界疗效：有效性、食管胃十二指肠镜检查的使用情况及出血并发症
Cancers (Basel). 2024 Aug 19;16(16):2878. doi: 10.3390/cancers16162878.
5
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306).卡维地洛预防肝硬化肝失代偿：基于新的非侵入性模型（CHESS2306）分层的具有临床显著门静脉高压的患者
Clin Mol Hepatol. 2025 Jan;31(1):105-118. doi: 10.3350/cmh.2024.0198. Epub 2024 Jul 11.
6
Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort Study.腹水是晚期胰腺腺癌不良预后因素，且可能治疗不足：一项前瞻性队列研究。
Clin Transl Gastroenterol. 2024 Jul 1;15(7):e00719. doi: 10.14309/ctg.0000000000000719.
7
Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal Syndrome.非选择性β受体阻滞剂在失代偿期肝硬化中的安全性及其在诱发肝肾综合征中的作用
Cureus. 2024 Apr 15;16(4):e58296. doi: 10.7759/cureus.58296. eCollection 2024 Apr.
8
[Current diagnostics and treatment of portal hypertension].[门静脉高压症的当前诊断与治疗]
Inn Med (Heidelb). 2022 Dec;63(12):1257-1267. doi: 10.1007/s00108-022-01427-4. Epub 2022 Nov 14.
9
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model.非侵入性预测因子在 NASH 肝硬化中的临床显著门脉高压：ANTICIPATE 模型的验证和基于实验室模型的开发。
Hepatol Commun. 2022 Dec;6(12):3324-3334. doi: 10.1002/hep4.2091. Epub 2022 Oct 10.